With its stock prices struggling, disease management giant Healthways could be a takeover target, according to a Goldman Sachs analyst. Another analyst suggested a pharmacy benefits manager could be a likely suitor. However, a Healthways executive said earlier this year that staying independent was advantageous for the company.
Trending:
Healthways called takeover target